Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
35.58
0.55 (1.57%)
At close: Jun 06, 2025, 3:59 PM
35.60
0.07%
After-hours: Jun 06, 2025, 04:20 PM EDT

Revenue by Geography

Period Ending Dec 31, 2023 Dec 31, 2022
United States Revenue 500M 500M
United States Revenue Growth 0.00% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue 61.95M 56.47M 56.16M 49.77M 46.95M 54.76M 45.96M 47.34M 44.63M 43.72M 41.8M 42.32M 35.46M 37.31M 33.34M 31.32M 30.05M 30.99M 23.11M 20.07M 22.54M 30.84M 25.47M 14.27M 10.15M
Selling, General, and Administrative Revenue Growth +9.72% +0.54% +12.85% +6.01% -14.26% +19.13% -2.90% +6.06% +2.10% +4.59% -1.24% +19.34% -4.96% +11.93% +6.42% +4.23% -3.03% +34.11% +15.14% -10.97% -26.89% +21.07% +78.47% +40.55% n/a
Research and Development Revenue 34.54M 34.67M 25.39M 63.58M 22.19M 30.31M 17.5M 14.97M 13.29M 10.09M 40.55M 12.67M 7.58M 7.45M 11.74M 6.5M 4.68M 7.62M 4.23M 4.17M 3.43M 7.28M 4.34M 4.99M 52.99M
Research and Development Revenue Growth -0.36% +36.55% -60.07% +186.55% -26.78% +73.19% +16.90% +12.64% +31.68% -75.11% +220.08% +67.17% +1.70% -36.53% +80.66% +38.88% -38.58% +80.09% +1.46% +21.51% -52.84% +67.80% -13.16% -90.58% n/a
Sales and Marketing Revenue 30.71M 27.6M 27.58M 28.51M 27.23M 26.89M 23.42M 24.53M 22.57M 21.07M 20.47M 20.16M 17.58M 19.11M 16.48M 17.02M 15.51M 17.53M 12.6M 12.44M 13.25M 16.84M 12.91M 8.38M 6.19M
Sales and Marketing Revenue Growth +11.27% +0.09% -3.27% +4.68% +1.29% +14.81% -4.53% +8.67% +7.10% +2.97% +1.52% +14.66% -7.99% +15.95% -3.18% +9.78% -11.53% +39.08% +1.27% -6.12% -21.30% +30.47% +54.07% +35.33% n/a